Search

everythinglearnresearchcommunity

for

Search:↓

Using a special laser and platelet-rich plasma together is safe and improves hair growth in men with hair loss.

CTP-543 is generally safe for treating alopecia areata.

The guideline emphasizes a multidisciplinary approach and informed consent for gender-affirming hormone treatment, with regular follow-ups and individualized care.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Telogen effluvium is a common, temporary hair loss condition often affecting young women.

Phloroglucinol may help improve hair loss by promoting hair growth and reducing oxidative stress.

Excessive eyelash growth from erlotinib may indicate positive tumor response and help treat madarosis.

TGF-β signaling is essential for new hair growth after wounds.

EtG in hair can help detect alcohol use but may be inaccurate in people with certain health conditions.

EGFR-TKIs can cause unexpected skin, nail, and hair issues.

Microneedle delivery of a special collagen shows promise for treating hair loss.

γδ T cells can prevent and treat alopecia areata, offering a new therapy option.

Transgender individuals may face specific skin issues during gender-affirming treatments, needing personalized care.

DanGuiBoHyulTangGami-Bang helps hair growth but doesn't extend the growth period or affect hair follicle cells significantly.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Epiregulin can help hair grow and may be useful for treating hair loss.

Bioengineered hair germs using special hydrogels can help regenerate hair follicles and treat hair loss.

Grateloupia angusta extract helps heal wounds faster and improve skin repair.

Integrative hair therapy improved hair loss and regrowth.

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

Overexpressing Tβ4 in goats' hair follicles increases cashmere production and hair follicle growth.

GLP-1RA therapy may increase the risk of hair loss.

FGF9 from certain T cells helps create new hair follicles during wound healing, which could potentially be used for hair loss treatments.

Thymosin β4 may boost hair growth by aiding stem cell movement and blood vessel formation.

The document concludes that hormone therapy is essential for treating gender dysphoria, with specific drugs and monitoring protocols recommended for safety and effectiveness.

Men with testicular cancer were less likely to experience baldness and severe acne.

γδ T cells adapt uniquely to different tissues in mice.

Goserelin and oestradiol treatment slightly improved hairiness but did not significantly change sebum production or hair characteristics in mildly hirsute women.